Royal London Asset Management Ltd. increased its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 1.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 453,820 shares of the company's stock after acquiring an additional 8,197 shares during the period. Royal London Asset Management Ltd. owned about 0.06% of Colgate-Palmolive worth $41,257,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in CL. Diamond Hill Capital Management Inc. bought a new stake in shares of Colgate-Palmolive in the fourth quarter worth $348,718,000. FMR LLC increased its stake in Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after buying an additional 2,674,807 shares during the last quarter. AMF Tjanstepension AB increased its stake in Colgate-Palmolive by 1,088.8% in the 4th quarter. AMF Tjanstepension AB now owns 2,569,394 shares of the company's stock valued at $233,584,000 after buying an additional 2,353,268 shares during the last quarter. Barclays PLC lifted its position in Colgate-Palmolive by 38.7% during the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after buying an additional 2,132,747 shares in the last quarter. Finally, State Street Corp boosted its stake in shares of Colgate-Palmolive by 3.8% during the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after buying an additional 1,784,411 shares during the last quarter. 80.41% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts recently weighed in on the stock. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an "overweight" rating on the stock in a report on Monday, February 3rd. StockNews.com lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Tuesday. UBS Group cut their target price on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Piper Sandler reduced their price target on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a report on Monday, January 6th. Finally, JPMorgan Chase & Co. upped their price objective on Colgate-Palmolive from $97.00 to $99.00 and gave the company an "overweight" rating in a research note on Friday, March 14th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $101.72.
Get Our Latest Report on CL
Colgate-Palmolive Stock Performance
Shares of NYSE:CL traded down $1.38 on Tuesday, reaching $89.52. 5,173,007 shares of the company's stock were exchanged, compared to its average volume of 4,226,853. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a fifty day moving average of $89.40 and a 200-day moving average of $93.95. The company has a market capitalization of $72.65 billion, a price-to-earnings ratio of 25.43, a PEG ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company earned $0.87 EPS. On average, research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a dividend of $0.52 per share. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. This represents a $2.08 annualized dividend and a yield of 2.32%. Colgate-Palmolive's dividend payout ratio is currently 56.82%.
Colgate-Palmolive announced that its Board of Directors has authorized a share buyback plan on Thursday, March 20th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 6.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's board believes its stock is undervalued.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.